Inmune Bio (INMB) Operating Expenses (2018 - 2026)
Inmune Bio (INMB) reported Operating Expenses of $1.48 million for Q2 2026, down 94.0% from $24.57 million a year earlier and down 74.6% from the prior quarter.
Powered by 
Analysis
Inmune Bio (INMB) Operating Expenses (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Inmune Bio's Operating Expenses came in at $20.2 million, down 64.1% year-over-year; for FY2025, it was $47.43 million, up 11.2% from FY2024.
- Operating Expenses has increased for three consecutive years, with a five-year compound annual growth rate of 31.1% (FY2020 to FY2025).
- By year, Operating Expenses came in at $42.65 million in FY2024 (+42.7%), $29.9 million in FY2023 (+13.6%), $26.33 million in FY2022 (-10.3%) and $29.33 million in FY2021 (+139.7%).
- The Q2 2026 figure ranks as the lowest quarterly Operating Expenses since Q2 2019.
- Year over year, Operating Expenses has now declined in each of the last four quarters, with an average decline of 2.8% over the last eight quarters.
- The high point for year-over-year Operating Expenses in five years was Q4 2021 (growth of 185.5%); the low point was Q2 2026 (a decline of 94.0%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $5.81 million (Q1 2026), $5.47 million (Q4 2025) and $7.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 15.99 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 11.12 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 11.14 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.53 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.00 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 6.66 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 4.84 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 7.09 Bn |
| 10 | Inmune Bio | 30.71 Mn | -50.14 Mn | - | 5.01 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 5.01 Mn |
| Jun 30, 2026 | 1.48 Mn |
| Mar 31, 2026 | 5.81 Mn |
| Dec 31, 2025 | 5.47 Mn |
| Sep 30, 2025 | 7.43 Mn |
| Jun 30, 2025 | 24.57 Mn |
| Mar 31, 2025 | 9.96 Mn |
| Dec 31, 2024 | 9.47 Mn |
| Sep 30, 2024 | 12.29 Mn |
| Jun 30, 2024 | 9.87 Mn |
| Mar 31, 2024 | 11.03 Mn |
| Dec 31, 2023 | 8.41 Mn |
| Sep 30, 2023 | 8.57 Mn |
| Jun 30, 2023 | 6.46 Mn |
| Mar 31, 2023 | 6.46 Mn |
| Dec 31, 2022 | 5.74 Mn |
| Sep 30, 2022 | 7.54 Mn |
| Jun 30, 2022 | 6.40 Mn |
| Mar 31, 2022 | 6.64 Mn |
| Dec 31, 2021 | 9.19 Mn |
API Access
Inmune Bio Operating Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-expenses&ticker=INMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-expenses", "ticker": "INMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-expenses&ticker=INMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();